- Genetic Susceptibility of Gastroduodenal Disease in Ethnic and Regional Diversity
-
Lim YJ
- KMID: 2070070
- Gut Liver.
- 2014 Nov;8(6):575-576.
- doi: 10.5009/gnl14313
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor Necrosis Factor-alpha and Interleukin-10 Gene Polymorphisms in Korean Patients with Inflammatory Bowel Disease
-
Kim TH, Kim BG, Shin HD, Kim JW, Kim CG, Kim JS, Jung HC, Song IS
- KMID: 1112188
- Korean J Gastroenterol.
- 2003 Nov;42(5):377-386.
BACKGROUND/AIMS: Although the importance of genetic susceptibility to inflammatory bowel disease (IBD) has been established by epidemiological studies, the genes involved remain poorly understood. The aim of this study... -
- CITED
-
- Close
- SHARE
-
- Close
- Association of TNFA Promoter Region Haplotype in Behcet's Disease
-
Park KS, Kim NY, Nam JH, Bang D, Lee ES
- KMID: 2157807
- J Korean Med Sci.
- 2006 Aug;21(4):596-601.
- doi: 10.3346/jkms.2006.21.4.596
Although the etiology of Behcet's Disease (BD; MIM 109650) remains to be clearly elucidated, levels of tumor necrosis factor alpha (TNF-alpha) have been reported to be significantly elevated in BD... -
- CITED
-
- Close
- SHARE
-
- Close
- Investigation of -308G>A and -1031T>C Polymorphisms in the TNFA Promoter Region in Polish Peptic Ulcer Patients
-
Salagacka , Zebrowska , Jelen A, Mirowski M, Balcerczak E
- KMID: 2070080
- Gut Liver.
- 2014 Nov;8(6):632-636.
- doi: 10.5009/gnl13224
BACKGROUND/AIMS: Tumor necrosis factor alpha (TNF-alpha) encoded by TNFA is a key mediator in inflammation, a precursor condition for peptic ulceration. Promoter polymorphisms of TNFA that influence its transcriptional activity... -
- CITED
-
- Close
- SHARE
-
- Close
- Antitumor Activity of TRAIL Recombinant Adenovirus in Human Malignant Glioma Cells
-
Kim KU, Seo SY, Heo KY, Yoo YH, Kim HJ, Lee HS, Choi SS, Hwang TH, Lee HJ
- KMID: 2157760
- J Korean Med Sci.
- 2005 Dec;20(6):1046-1052.
- doi: 10.3346/jkms.2005.20.6.1046
Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL) has been reported to specifically kill malignant cells but to be relatively nontoxic to normal cells. One of disadvantages to previous in vivo protocols... -
- CITED
-
- Close
- SHARE
-
- Close
